U.S. Insurance Stock News

MACOM Technology Solutions Holdings (MTSI) has renewed attention on its stock after announcing new RF and optical components for direct to device SATCOM payloads, aimed at next generation satellite communication systems. See our latest analysis for MACOM Technology Solutions Holdings. The recent SATCOM product announcements come after a sharp run in the stock, with an 84.44% 3 month share price return and a very large 5 year total shareholder return, although the shares have slipped around 2%...

Federal Communications Commission calls for early license renewals for Disney's ABC broadcast stations, years before their usual expiration. The move is connected to an ongoing investigation and opens a window for public petitions or objections in the coming weeks. This step introduces an additional regulatory process for The Walt Disney Company (NYSE:DIS) beyond routine compliance. The Walt Disney Company, through its ABC network, is a major player in US broadcast television alongside its...

Earlier this week, Sherwin-Williams announced its 2026 “Loneliest Color” selection, Offbeat Green SW 6706, a vivid citric lime green highlighted through cultural collaborations and limited-edition products that bring the shade into everyday experiences. By spotlighting its least tinted shade each year, the company is using an unconventional marketing platform to link brand identity with individuality and emotionally driven design choices in the home. We’ll now examine how UBS’s downgrade,...

If you are wondering whether Corteva at around US$77 a share still offers value or is starting to look stretched, the next few sections will help you frame that question clearly. The stock has pulled back recently, with returns down 3.9% over the past week and down 7.7% over the past month, although it remains up 14.3% year to date and 9.8% over the past year. Recent headlines around Corteva have focused on its position within the wider materials sector and how investors are reassessing risk...

AM Best recently affirmed the A- (Excellent) Financial Strength Rating and the "a-" Long-Term Issuer Credit Rating of North End Re Ltd. (Bermuda), a subsidiary of Brookfield Wealth Solutions, maintaining a stable outlook based on its strong balance sheet, adequate operating performance, and support from its parent. A key element of this rating affirmation is AM Best’s recognition of North End Re Ltd.’s plans to assume annuity-type business from European and Asian markets, highlighting the...

Zions Bancorporation National Association (NasdaqGS:ZION) has appointed Daniel J. Ryan, a retired PwC partner, to its board of directors. Ryan brings more than 40 years of experience in public banking, governance, risk, and cybersecurity oversight. His appointment expands the board and includes immediate roles on key governance, audit, and risk related committees. Zions Bancorporation, a regional banking company, operates in a sector where regulators and investors pay close attention to...

Chevron’s CEO has indicated the company will not commit new investment to Venezuela without changes to taxes and royalties. The comments clarify that current talks with the Venezuelan government focus on fiscal terms rather than immediate production expansion. Chevron remains the only major US operator in Venezuela, giving its stance outsized importance for future foreign energy investment in the country. For investors tracking NYSE:CVX, this update adds a fresh layer to the story around...

AT&T (NYSE:T) is confronting a surge in copper thefts targeting its legacy network infrastructure. The thefts are being linked to higher copper demand from the build out of AI data centers. In response, AT&T has launched a high profile reward campaign offering a substantial payout for information leading to arrests. AT&T, through its core wireless and wireline communications services, relies heavily on extensive copper based infrastructure that supports parts of its network. The current...

Oruka Therapeutics (ORKA) stock is drawing fresh attention after positive interim Phase 2a data for lead antibody ORKA-001 in moderate to severe plaque psoriasis, as well as an expanded IL-23 license that now clearly covers inflammatory bowel disease. See our latest analysis for Oruka Therapeutics. The latest data and licensing news come after a sharp move in the share price, with a 1-day share price return of 8.88% and a 7-day share price return of 7.42%. However, the 30-day share price...

Flex (NasdaqGS:FLEX) has completed its acquisition of Electrical Power Products (EP²). The company has also finalized plans to separate its Power and Cloud business into a new entity, often referred to as SpinCo. These moves expand Flex's reach in grid modernization, customized power control, utility markets, and AI data center infrastructure. The EP² deal is described as accretive to earnings, and the related credit agreement is now closed. For investors watching electrification and AI...

Recent performance context Clover Health Investments (CLOV) has drawn attention after a sharp share price move, with the stock closing at US$3.99. Investors are considering this in light of its recent returns and its ongoing Medicare Advantage focused business. See our latest analysis for Clover Health Investments. The latest 1 day share price return of 9.32% comes after a softer 7 day share price return of 4.55%. However, the 30 day share price return of 52.87% and 90 day share price return...

Olaplex Holdings (NasdaqGS:OLPX) has reached a court approved settlement in consolidated shareholder derivative litigation. The settlement requires corporate governance reforms and the withdrawal of related legal claims. Insurers are set to cover agreed legal fees as part of the settlement terms. The court has granted preliminary approval. The settlement marks a key moment for the company’s risk profile and oversight framework. Olaplex Holdings, known for its professional and consumer hair...

Viking Therapeutics (VKTX) is back in focus as investors track upcoming clinical catalysts for its obesity drug VK2735, including Phase 1 maintenance trial results in Q3 2026 that could influence expectations for the stock. See our latest analysis for Viking Therapeutics. Recent excitement around VK2735 has not prevented some cooling in the stock, with the share price down 16% year to date and the 90 day share price return also weaker, even as the 1 year and 5 year total shareholder returns...

Lamar Advertising recently reported that outdoor advertising demand remains healthy, with local markets solid and national advertisers returning, while digital billboards now make up nearly one-third of billboard billings and enhance its ability to flex ad inventory. Management’s decision to keep full-year AFFO guidance intact, coupled with the possibility of a dividend increase if trends persist, signals confidence in the cash-generating strength of its expanding digital footprint. Next,...

Wondering whether Gartner at around US$164.87 offers value or just more volatility? This article walks through what the current price really implies for you as a shareholder or potential buyer. The stock has risen 2.3% over the past week and 10.3% over the past month, yet remains down 30.4% year to date and has fallen 60.9% over the past year. This raises questions about how the market is reassessing its growth prospects and risk profile. Recent coverage has focused on how market sentiment...

Zymeworks recently reported positive updates across its oncology portfolio, including encouraging Phase 1 data for ZW191, advancement of its pan‑RAS ADC platform, and regulatory progress for zanatumab with a US PDUFA date set for August 25, 2026 and a supplemental BLA filing in China that triggered milestone payments from Jazz Pharmaceuticals and BeiGene. These clinical and regulatory advances, alongside a new US$125,000,000 share repurchase authorization and continued interest from global...

GE HealthCare Technologies (NasdaqGS:GEHC) received FDA clearance for its MIM Contour ProtégéAI+ 2.0 software. The AI enabled tool is designed to support more automated and precise radiation therapy planning for cancer patients. The clearance includes a Predetermined Change Control Plan that allows future AI features to be deployed more quickly. For investors watching GE HealthCare's oncology and imaging efforts, this update adds another piece to the broader medical technology story. The...

Zhihu (NYSE:ZH) reported Q1 2026 revenue of C¥651.6 million, with a basic EPS loss of C¥0.11 and a quarterly net income loss of C¥8.5 million. Over the trailing twelve months, revenue totaled C¥2.7 billion and the EPS loss stood at C¥2.42. The company has seen quarterly revenue move between C¥643.5 million and C¥859.2 million since Q4 2024, with basic EPS shifting from a profit of C¥1.01 in Q4 2024 to a loss of C¥2.66 in Q4 2025, followed by the latest quarter’s narrower loss. As a result,...

How W. R. Berkley’s recent performance looks in context W. R. Berkley (WRB) stock has delivered mixed returns recently, with a gain over the past week but declines over the past month and past 3 months, leaving the year to date performance in negative territory. Over a longer horizon, the stock shows a very different picture, with multi year total returns over the past 3 and 5 years that are well ahead of the recent shorter term pullback. This contrast may catch your eye if you track...

Earlier in 2026, Pacific Gas and Electric Company (PG&E) announced it had surpassed 1 million customers with solar systems connected to its grid, the highest number of any U.S. utility, reflecting large-scale adoption of customer-owned clean energy in California. The utility is also turning this vast base of rooftop solar and paired battery systems into virtual power plants through grid automation and advanced forecasting, aiming to strengthen reliability while integrating more renewable...

Viasat (VSAT) has quickly moved back into focus after two developments: a new role supplying satellite communications for NOAA’s Hurricane Hunter aircraft via Lockheed Martin, and quarterly results that missed revenue and earnings expectations. See our latest analysis for Viasat. Those mixed signals are showing up in the share price too, with the stock delivering a 30 day share price return of 11.22% and a year to date share price return of 93.81%. The 1 year total shareholder return is about...

Wondering if LPL Financial Holdings at around US$291.84 is priced for opportunity or risk? This article walks through what the current valuation really implies for you as a shareholder or potential buyer. The stock has risen about 9.8% over the past week, but is still down around 10.9% over the past month, 19.3% year to date, and 22.9% over the last year. This comes even after rising 47.3% over three years and 117.4% over five years. Recent coverage has focused on how wealth management...

Teva Pharmaceutical Industries (NYSE:TEVA) has launched AHZANTIVE, a biosimilar to Eylea, in Europe. The product targets retinal conditions treated with Eylea and expands Teva's presence in ophthalmology. The launch adds to Teva's biosimilars portfolio and supports its Pivot to Growth focus on complex biologic medicines. Teva enters this news cycle with its stock at $34.43 and very large multi year gains, including a 99.6% return over the past year and a 198.6% return over five years. Short...

IDEXX Laboratories stock: earnings beat and product expansion put diagnostics focus in the spotlight IDEXX Laboratories (IDXX) is back on investors’ radar after a first quarter earnings and revenue beat, an upgraded 2026 outlook, and a fresh expansion of its Fecal Dx parasite testing platform. See our latest analysis for IDEXX Laboratories. The recent earnings beat, upgraded 2026 outlook, and broader Fecal Dx parasite menu come after a period where the share price has eased, with the 90 day...